Stock Taper
SCREENER COMPARE ANY 2 STOCKS
SABSW
SAB BIOTHERAPEUTICS, INC.
NASDAQ
$0.03
▲ UP 1.57% (0.00)

KEY STATISTICS

Market Cap$246.60 K
52w High$0.05
52w Low$0.03
Dividend Yield—
Frequency—
P/E-0.07
Volume9.94K
Shares Out.9.56M

COMPANY

LEADERSHIP

Samuel J. Reich
CHIEF EXECUTIVE
Samuel J. Reich

COMPENSATION 2026

Salary$0
Stock Awards$0
Incentive Plan Pay$0
All Other Comp.$0
Total$0

ABOUT

SECTOR
Healthcare
WENT PUBLIC
October 25, 2021
METHOD OF GOING PUBLIC
SPAC
FULL TIME EMPLOYEES
86

UPCOMING EARNINGS

DateNov 17, 2026
DayTuesday
Rev. Est.$125.00K
NOV
17
TUE

PRICE

$0.03 ▲ UP 1.57% (+$0.00)
$0.03$0.03$0.03$0.031:00 PM1:09 PM1:17 PM1:26 PM1:35 PM1:43 PM1:52 PM0.03

About SAB Biotherapeutics, Inc.

https://www.sab.bio ↗

SAB Biotherapeutics, Inc. is a biopharmaceutical company developing immunotherapies for infectious, autoimmune, and cancer diseases, with products like SAB-142, SAB-176, and SAB-301, based in Sioux Falls, SD, and Cambridge, MA.

INDUSTRY

Biotechnology

A PRODUCT SAB BIOTHERAPEUTICS, INC. IS KNOWN FOR

SAB-142
SAB-142

A clinical-stage, fully human anti-thymocyte immunoglobulin (hATG) in Phase 2b trials, developed as a potential disease-modifying therapy to preserve insulin-producing cells and delay or prevent progression in new-onset Stage 3 Type 1 Diabetes.

COMPETITORS

COMPETITOR
EBS COMPARE
GRFS COMPARE
REGN COMPARE
SNY COMPARE
VRTX COMPARE

Revenue by Products

IconPRODUCTFY2022
Grant$23.9M

INSTITUTIONAL OWNERSHIP

SHARES OWNED
9.93%
HOLDERS
13
TOP 12 OF 13 · RANKED BY POSITION SIZE
Lmr Partners Llp
539.6K sh · $14.08K
Morgan Stanley
146.4K sh · $3.71K
Clear Street Group Inc.
79.0K sh · $1.85K
Clear Street LLC
78.8K sh · $2.63K
Gts Securities LLC
41.0K sh · $1.07K
Susquehanna International Group, Llp
26.3K sh · $750
Ubs Group AG
23.4K sh · $539
Walleye Trading LLC
11.4K sh · $268
Wolverine Asset Management LLC
1.8K sh · $47
Newedge Advisors, LLC
1.1K sh · $33
Toronto Dominion Bank
200 sh · $5
Bank Of America Corp /De/
200 sh · $5

RATINGS SNAPSHOT

Overall rating: B

DCFROEROAD/EP/EP/B
Discounted Cash Flow5
Return On Equity1
Return On Assets1
Debt To Equity4
Price To Earnings1
Price To Book5
Overall Score3

INSIDER TRADES

★
OFFICER: CHIEF MEDICAL OFFICER
Kropotova Alexandra
Sale · 988 shares
2026-06-25
★
OFFICER: CHIEF MEDICAL OFFICER
Kropotova Alexandra
Sale · 988 shares
2026-03-24
★
DIRECTOR, OFFICER: PRESIDENT
Sullivan Eddie Joe
Purchase · 3.0M shares
2026-02-03
★
DIRECTOR, OFFICER: CEO
Reich Samuel J
Purchase · 4.8M shares
2026-02-03

SECTORS PEERS

PEERPRICE
KTTA$0.56COMPARE
REVB$1.05COMPARE
DRMA$1.34COMPARE
OCEA$0.00COMPARE
NUWE$0.89COMPARE
VINC$0.01COMPARE
SYRS$0.00COMPARE
BACK$0.00COMPARE